Business · 12/01/2017Updated: 10/17/2026 · 1 min read
FDA Announces Joint Meeting of Ophthalmic Devices Panel and Risk Communication Advisory Committee
Summary
The FDA is hosting a public meeting of the Ophthalmic Devices Panel and the Risk Communication Advisory Committee to provide advice on FDA's regulatory issues, following a recent proposal by the committee.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →